Disorders


 

DRPLA


Synonym(s): Dentatorubral-Pallidoluysian Atrophy, Naito-Oyanagi Disease

 

GeneReviewOMIM

GeneLocusProtein
ATN112pAtrophin-1

Laboratory Test Method Prenatal Carrier *
Addenbrooke's Hospital, Molecular Genetics Laboratory - Cambridge, Great Britain• Targeted mutation analysis
  
Alberta Children's Hospital, Molecular Diagnostic Laboratory - Calgary, Canada• Targeted mutation analysis
  
Athena Diagnostics Inc, Reference Lab - Worcester, MA, USA• Targeted mutation analysis
  
Baylor College of Medicine, Medical Genetics Laboratories - Houston, TX, USA• Targeted mutation analysis
  
Center for Genetics at Saint Francis, Genetics Laboratory - Tulsa, OK, USA• Targeted mutation analysis
 
Center for Human Genetics, Bioscientia GmbH - Ingelheim, Germany• Targeted mutation analysis
 
Center for Human Genetics, Inc - Cambridge, MA, USA• Targeted mutation analysis
 
Centogene AG, Rare Disease Company - Rostock, Germany• Targeted mutation analysis
 
Centre for Cellular and Molecular Biology, Molecular Diagnostics Division - Hyderabad, India• Targeted mutation analysis
 
Centre for DNA Fingerprinting and Diagnostics, Diagnostics Division - Hyderabad, India• Targeted mutation analysis
 
Cyprus Institute of Neurology and Genetics, Neurogenetics Department - Ayios Dhometios, Cyprus• Targeted mutation analysis
 
GENETAQ, Molecular Genetics Centre - Malaga, Spain• Targeted mutation analysis
 
GGA - Galil Genetic Analysis - Kazerin, Israel• Targeted mutation analysis
 
Instituto de Medicina Genmica, IMEGEN - Paterna, Spain• Targeted mutation analysis
• Linkage analysis
 
IWK Health Centre, Molecular Diagnostic Laboratory - Halifax, Canada• Targeted mutation analysis
 
Justus-Liebig University, Institute of Human Genetics - Giessen, Germany• Targeted mutation analysis
 
Karolinska University Hospital, Department of Clinical Genetics - Stockholm, Sweden• Targeted mutation analysis
 
LabPLUS - Auckland City Hospital, Molecular Genetics Laboratory - Diagnostics Genetics - Auckland, New Zealand• Targeted mutation analysis
 
Mayo Clinic - Minnesota, Molecular Genetics Laboratory - Rochester, MN, USA• Targeted mutation analysis
 
Medgene, MedGene - Bratislava, Slovakia• Targeted mutation analysis
 
MGZ München, Medizinisch Genetisches Zentrum Mnchen - München, Germany• Targeted mutation analysis
 
North York General Hospital, Molecular Genetics Laboratory - Toronto, Canada• Targeted mutation analysis
 
Praxis fuer Humangenetik Wien - Vienna, Austria• Targeted mutation analysis
 
Pronto Diagnostics Ltd., ProntoLab - MLPA Lab - Tel Aviv, Israel• Targeted mutation analysis
 
Ruhr University, Human Genetics - Bochum, Germany• Targeted mutation analysis
 
Samsung Medical Center, Department of Laboratory Medicine and Genetics - Seoul, South Korea• Targeted mutation analysis
 
Seoul National University Hospital, Molecular Diagnostics Laboratory - Seoul, South Korea• Targeted mutation analysis
 
Sheffield Children's NHS Foundation Trust, Sheffield Diagnostic Genetics Service - Sheffield, Great Britain• Targeted mutation analysis
 
Sir Ganga Ram Hospital, Center of Medical Genetics - New Delhi, India• Targeted mutation analysis
 
Sistemas Genomicos, Medical Genetics Unit - Paterna, Spain• Targeted mutation analysis
• Linkage analysis
 
University Clinic Freiburg, Institute for Human Genetics - Freiburg, Germany• Targeted mutation analysis
 
University Hospital of Antwerp, Department of Medical Genetics - Wuyts Lab - Edegem, Belgium• Targeted mutation analysis
 
University Hospital of Tuebingen, Medical Genetics Tuebingen - Tuebingen, Germany• Targeted mutation analysis
 
University of Tennessee Medical Center, Molecular Diagnostics Laboratory - Knoxville, TN, USA• Targeted mutation analysis
 
University of Turku, Diagnostic DNA Laboratory - Turku, Finland• Targeted mutation analysis
 

* Carrier column is relevant to autosomal recessive and X-linked inheritance; column will be blank when it is not relevant (e.g. autosomal dominant inheritance, microdeletions/duplications) and/or is not offered by the lab.

Loading...